Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03347539 · ClinicalTrials.gov registry record

Implants on Mobile Health Unit

A clinical trial, sponsored by University of Chicago.

Completed
Registry status
1
Enrollment target

NCT03347539: Completed study, sponsored by University of Chicago.

NCT03347539 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03347539 has completed, sponsored by University of Chicago.

COMPLETED
Registry status
1 participants
Enrollment target

Study Summary

This study explores reasons why adolescents choose to receive a nexplanon implant and remove a Nexplanon implant. Nexplanon is provided as part of the standard of care on the University of Chicago mobile health unit. This study explores reasons for implantation and removal of Nexplanon on this mobile health unit.

Primary Outcome

Information will be collected through a survey regarding why adolescents choose to receive Nexplanon.

Interventions

  • DEVICE Nexplaon

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2017-09-13
Est. Completion 2020-04-06
University of Chicago

796 total trials

What the finished NCT03347539 record still lists

NCT03347539 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Nexplaon is the first listed.

NCT03347539 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03347539 about?

NCT03347539 is a clinical study titled "Implants on Mobile Health Unit". This study explores reasons why adolescents choose to receive a nexplanon implant and remove a Nexplanon implant. Nexplanon is provided as part of the standard of care on the University of Chicago mobile health unit. This study explores reasons for implantation and removal of Nexplanon on this mobil...

What is the current status of trial NCT03347539?

This trial is currently completed. The enrollment target is 1 participants. The study started on 2017-09-13. Estimated completion is 2020-04-06.

What interventions are being tested in trial NCT03347539?

The interventions under investigation include: Nexplaon (DEVICE).

Who is sponsoring clinical trial NCT03347539?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03347539, the US trial registry maintained by the National Library of Medicine. NCT03347539 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.